Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-115547

Chief Business Officer gave up 1,724 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan Chief Business Officer 2021-09-10 Shares withheld for taxes −1,724 $4.59 $7,913 22,627 D: show line 1 in the form
Loading xslF345X03/tm2127534-1_4seq1.xml…